Endocrinology Vol. 142, No. 7 3231-3238
Copyright © 2001 by The Endocrine Society
Isolation and Characterization of a Novel Member of the Relaxin/Insulin Family from the Testis of the Frog Rana esculenta1
Gianluca de Rienzo2,
Francesco Aniello2,
Margherita Branno2 and
Sergio Minucci2
Dipartimento di Medicina Sperimentale-Sezione di Fisiologia Umana e
Funzioni Biologiche Integrate "F. Bottazzi" (G.D.R., S.M.),
Seconda
Università degli Studi di Napoli-Via Costantinopoli, 16 80138
Napoli, Italy; and Laboratorio di Biochimica e Biologia Molecolare
(F.A., M.B.), Stazione Zoologica "A. Dohrn"- Villa Comunale 121
80132 Napoli, Italy
Address all correspondence and requests for reprints to: Dr. Sergio Minucci, Dipartimento di Medicina Sperimentale-Sezione di Fisiologia Umana e Funzioni Biologiche Integrate "F. Bottazzi" Seconda Università degli Studi di Napoli-Via Costantinopoli, 16 80138 Napoli, Italy. E-mail: sergio.minucci{at}unina2.it
 |
Abstract
|
|---|
A complementary DNA (cDNA) encoding a frog relaxin/insulin member
family (fRLX) from testis cDNA library was isolated and characterized.
The fRLX cDNA predicted a 155-amino acid protein with a low homology to
mammalian RLF and relaxin. Northern blot analysis revealed a single
transcript expressed in the interstitial compartment, RT-PCR, evidenced
that fRLX is expressed at low levels in the oviduct and ovary too. The
predicted mature fRLX protein, composed of the signal peptide, B, C,
and A domains, has conserved amino acid sequences in the characteristic
functional domains. A different expression of the transcript was found
during the frog reproductive cycle, with a peak in Spring. After
administration of ethane dimethane sulfonate, by in situ
hybridization, fRLX messenger RNA disappeared from the interstitial
compartment and reappeared again at the time of generating of a new
population of Leydig cells (LC), strongly indicating that LC are the
interstitial cell type expressing fRLX. Preliminary results obtained by
in situ hybridization, performed on testis of
hypophysectomized frogs evidenced a pituitary control of fRLX
expression. This study is the first cloning of a relaxin/insulin family
member in a nonmammalian vertebrate. In addition, because fRLX
expression changes during the annual cycle suggesting its involvement
in spermatogenesis, fRLX may be considered a new marker for the study
of spermatogenesis in the Rana esculenta.
 |
Introduction
|
|---|
WE HAVE isolated from the testis of
the frog Rana esculenta, a complementary DNA (cDNA) clone
coding for a novel relaxin/insulin family member (fRLX) that present a
modest homology with mammalian relaxin and relaxin-like factor (RLF).
RLF was originally isolated from porcine, human and mouse testis cDNA
libraries (1, 2, 3), whereas relaxin is a classical endocrine
hormone produced by the ovary, placenta, or uterus in many mammalian
species (4).
Recently RLF has been isolated and characterized in other
mammalian species (5, 6, 7, 8). Its sequence in all species
shows the common B-C-A heteromeric structural organization in which the
B and A domain are covalently linked by two intradomain disulfide bonds
and in the B domain the highly conserved R-XXX-R relaxin receptor
binding motif is present (9).
Several studies showed that RLF is expressed in fetal and adult testis
(1, 3) and, in particular at a high level in the
testicular Leydig cells of all mammalian species studied so far
(9). It has also been detected at a low level in the
placenta (10), theca cells, granulosa cells, corpus
luteum, and ovarian stroma (11, 12). The expression of RLF
in reproductive tissues suggests a potential involvement in
reproduction; this is supported by the observation that transcription
of the gene is mediated by steroidogenic factor I (SF-I)
(13).
The functional role of the relaxin/insulin proteins in the testis is
still not fully understood, although male mice with an inactive RLF
gene show altered spermatogenesis (14) and male
RLF-knockout mice exhibit bilateral cryptorchidism that results in
abnormal spermatogenesis and infertility, probably due to a failure of
the testis to descend properly during fetal development (15, 16).
No information about RLF expression is found in nonmammalian species.
In the present study we report, for the first time, the cloning of a
novel relaxin/insulin family member in the testis of an anuran,
Rana esculenta, a seasonal breeder with a spermatogenic
cycle regulated by endocrine and environmental factors and a cystic
organization of its testis that favors the study of spermatogenesis
(17).
 |
Materials and Methods
|
|---|
Animals
Fifty male adult frogs of Rana esculenta were
supplied monthly by a local dealer, and five additional female adult
frogs were captured in January. The animals were killed by decapitation
under anesthesia (MS-222 Sigma, St. Louis, MO) and the
testes, Harderian gland (HG), kidneys, livers, brains, ovaries,
oviducts, and muscles were dissected, quickly frozen by immersion in
liquid nitrogen and stored at -80 C until RNA extraction. In addition,
five testes were fixed in Bouins fluid, processed for histological
observation, and 5 µm paraffin section were stained with
hematoxylin-eosin for a monthly check of the testicular activity.
Preparation of poly (A)+ RNA
Total RNA from the testes, HGs, kidneys, livers, brains,
muscles, ovary, and oviduct of the frog Rana esculenta were
prepared with a modification of Chomczynski and Sacchi procedure
(18). Poly (A)+ was purified by
oligo (dT) cellulose chromatography (19).
Isolation and sequencing of tissue-specific cDNA clones
The total cDNA inserts derived from 3 x
106 pfu from the two libraries prepared from poly
(A)+ messenger RNA (mRNA) extracted from the
testis and Harderian gland (HG) as described by Aniello et
al. (20) were rescued as Bluescript plasmids (SK+) by
a helper phage mediate in vivo excision as described by the
manufacturer (Stratagene, Cambridge, UK).
The maxiexcision of the HG cDNA library was used to prepare the probe
to screen the maxiexcision of testis library.
In particular, 10 µg of plasmidic DNA obtained from HG cDNA library
maxiexcision were digested with cloning restriction enzyme
(EcoRI-XhoI) and the digestion product containing
insert of 0.52.5 kb was labeled with the random primer method using a
mixture of [
32P]-dCTP and
[
32P]-dATP (Amersham Pharmacia Biotech, Aylesburg, UK).
A quantity of 2 x 104 testis library
plasmidic clones (1000 colonies/plate) were plated on LB-ampicilline
agar plates (50 µg/ml) and incubated overnight at 37 C. Colonies
containing the pBluescript with the cloned DNA inserts were transferred
on nylon filters (Colony/Plaque Screen NEN Life Science Products, Boston) and hybridized with the probe described above
in 5x SSC, 5x Denhardts, 100 µg/ml salmon sperm DNA and 50
mM sodium phosphate at pH 7.0 overnight at 65 C. After the
hybridization, plasmidic DNA was prepared from 14 negative clones as
described (19). The directionated inserts
(5'EcoRI- 3'XhoI) were sequenced on both strands
by dideoxinucleotide procedure (21).
5'-RACE-PCR
The 5'-RACE-PCR was performed using 1 µg of total RNA prepared
from March testis according to the manufacturers instructions
(Life Technologies, Inc., Paisley, UK) employing the poly
(A)+ RNA from testis, the cDNA-specific primers
(test 1C: 5'-cacaggacatgacaactgtccgaata-3', test 1D:
5'-acatccatgccttggcaccaaaccg-3', test 1F: 5'-cggtatagccaacgtaaga-3')
and the universal primer (5'-ggccacgcgtcgactagtac-3', Life Technologies, Inc.). RACE-PCR was run for 35 cycles at an
annealing temperature of 68 C. The PCR product was separated on 1%
agarose gel, purified by QIAGEN gel extraction kit
(QIAGEN, Hilden, Germany) and cloned into the pGEM-T
vector (Promega Corp., Heidelberg, Germany). Sequence
analysis of PCR-amplified cDNA was performed as describe above.
Phylogenetic analysis
To trace the primary sequence relationships of fRLX with other
known RLF and relaxin, a phylogenetic analysis was performed using
amino acid sequence of seven RLFs and seven relaxins. Sequences were
managed and aligned using BioEdit version 4.5.8 software
(22). For the phylogenetic tree a Kimura 2p distance
matrix was obtained and the tree was constructed using UPGMA
(Unweighted Pair-group Method using Arithmetic Averages) clustering
procedure through the Neighbor joining method using the PHYLIP computer
package (23). The robustness of the phylogenetic
hypothesis was tested by bootstrapping. To assess branch reliability,
all bootstrap analyses of amino acids involved 500 replications of the
data.
Northern blot analysis
Total RNA (20 µg for each sample) was fractionated by
electrophoresis in 2.2 M formaldehyde on 1% agarose gel
and then transferred to a nitrocellulose membrane by overnight
capillary blotting. The filters were prehybridized for 56 h at 65 C
in 5x SSC, 5x Denhardts, 100 µg/ml salmon sperm DNA and 50
mM sodium phosphate at pH 7.0 and hybridized to test 1
probe (2 x 106 cpm/ml) at 65 C overnight.
The filters were washed twice for 30 min at 65 C in 0.2x SSC and 0.1%
SDS and finally were exposed to x-ray film (HR-H, Fuji Photo Film Co., Ltd., Tokyo, Japan).
RT-PCR
fRLX and frog heat-shock protein 90 (HSP90) mRNA levels were
measured by RT-PCR amplification.
First-strand cDNA was synthesized using 5 µg total RNA from a January
ovary, oviduct and testis, 500 ng/µl
oligo(dT)18 primer (Promega Corp.,
Heidelberg, Germany) and 200 U Superscript II RT enzyme (Life Technologies, Inc.) in a total volume of 20 µl according to
the manufacturers instructions (Life Technologies, Inc.). Three microliters of this cDNA template was then used for
the PCR (50 µl volume) with 1.5 mM
MgCl2, 1 x PCR buffer (10 mM
Tris-HCl, pH 9.0, 50 mM KCl, and 0.1% TritonX-100), 0.5 U
Taq DNA polymerase (Promega Corp., Heidelberg,
Germany) and 10 pmol oligonucleotide primers (fRLX forward primer:
5'-tgtatgcagagagccacat-3', fRLX reverse primer:
5'-gagtgcttgctctgcagac-3', HSP90 forward primer:
5'-tggctggacagctaacatg-3', HSP90 reverse primer:
5'-tcaggacatcacatactggc-3'). The RT-PCR product sizes were 265 bp for
fRLX and 723 bp for HSP90.
An appropriate region of HSP90 cDNA was used as control.
Amplifications, carried out for 30 cycles, were as follows: 94 C for 1
min, 53 C for 1 min, and 72 C for 1 min. Amplification products were
electrophoresed on 1.5% agarose gel in 1x TAE buffer.
Semiquantitative analysis of mRNA levels was carried out by the GEL DOC
1,000-UV fluorescent gel documentation system (Bio-Rad Laboratories, Inc., Hercules, CA).
In situ hybridization
Frog testes were perfusion fixed in Bouins fluid for 24 h
at room temperature. The tissues were dehydrated and embedded in
paraffin. Five-micrometer paraffin sections were dewaxed in xilol twice
for 10 min each time and transferred through descending grades of
ethanol to diethilpyrocarbonate-treated PBS for 5 min. The sections
were prefixed in 4% paraformaldehyde in 0.5 M NaCl, 0.1
M MOPS, pH 7.5, for 30 min at room temperature, then washed
in PBS. This was followed by incubation in 10 µg/ml proteinase K in
100 mM Tris-HCl, pH 7.2, and 1 mM EDTA for 10
min at room temperature. The sections were postfixed in 4%
paraformaldehyde in 0.5 M NaCl, 0.1 M MOPS, pH
7.5, for 30 min at room temperature. Slides were washed in PBS for 5
min, then transferred in 2 x SSC for 3 min. Before hybridization,
the sections were kept in Tris-glycine buffer for 45 min. The
hybridization solution comprised 40% deionized formamide, 5x SSC, 1x
Denhardts solution, 100 µg/ml sonicated salmon testes, 100 µg/ml
transfer RNA, and 80 ng digoxigenin-labeled complementary RNA (cRNA)
probe (see below). Eighty microliters of hybridization solution were
added on each slide. Hybridization proceeded overnight at 60 C in a
moist chamber. Slides were rinsed 3 times in 5 x SSC for 20 min
each, then washed in posthybridization buffer (0.5x SSC, 20%
deionized formamide) for 40 min at 60 C. Ribonuclease (RNase) A
digestion was then carried out to remove unspecifically bound
single-stranded cRNA probe. Sections were incubated for 30 min at 37 C
in RNase buffer (0.5 M NaCl, 10 mM Tris-HCl, pH
7, 1 mM EDTA) containing 100 µg/ml RNase A, and rinsed in
RNase buffer without the enzyme for 15 min at 37 C. The slides were
washed in posthybridization buffer for 30 min at 60 C and rinsed in
2 x SSC for 30 min at room temperature. The sections were
incubated in 1% blocking solution [1% blocking reagent
(Roche Diagnostics, Basel, Switzerland) in MBT buffer, 0.1
M maleic acid, 0.15 M NaCl, pH 7.5] for 10
min. The slides were incubated overnight at 4 C with an alkaline
phoshatase-conjugated sheep anti digoxigenin antibody
(Roche Diagnostics) diluted 1:2000 in MBT buffer. Sections
were rinsed 4 times in TBS for 10 min each and then in solution B
(0.1% Tween-20, 0.5 mg/ml levamisol) for 10 min before the color
detection substrate solution was applied [1 ml BM purple
(Roche Diagnostics), 10 µl 100x solution B per slide],
sections were incubated overnight in the dark at room temperature, and
the reaction was stopped by rinsing the slides in PBS, 1 mM
EDTA for 10 min at room temperature. Sections were dehydrated and
mounted. The 1222-bp test1 pBluescript II SK+ clone was linearized with
either EcoRI or XhoI to create antisense or sense
cRNA probes using T7 or T3 RNA polymerases, respectively. The sense
(control) and antisense cRNA probes were prepared by in
vitro transcription using (digoxigenin-UTP Roche
Diagnostics) exactly as recommended by the manufacturer.
Ethane 1,2-dimethane sulfonate (EDS) treatment
In February, adult frogs (n = 25) were divided into three
groups as follows: 1) 10 animals that received a single injection of
EDS [100 mg/kg body weight in dimethyl sulfoxide (DMSO)-water, 1:3
vol/vol]; 2) 10 animals that received a single injection of DMSO; 3) 5
animals were used as initial controls at the beginning of the
treatment. The EDS- and DMSO-injected frogs were killed on days 4 and
28 (5 animals/group/each time) after treatment and the testes were
removed and fixed for in situ hybridization.
Hypophysectomized (PDX) animals
In January, adult frogs (n = 25) were divided into two
groups as follows: 1) 20 animals were hypophysectomized
(24) and kept in captivity with food and meal ad
libitum for 30 days; 2) 5 animals were kept in captivity with food
and meal ad libitum for 30 days. At the end of the
experiment, the testes of all the animals were removed and fixed for
in situ hybridization.
 |
Results
|
|---|
Cloning and characterization of fRLX cDNA
To identify frog testis-specific genes, we performed an
experimental technique using two different cDNA libraries, from testis
and Harderian gland (HG) of Rana esculenta. The testis
library was screened with an HG heterogeneous probe representing the
total inserts of HG library cDNAs. With this method we have been able
to isolate 14 negative clones, probably expressed only in the testis.
We report here on the analysis of clone test 1, corresponding to a
testis-specific gene. Sequence analysis of this clone showed that it
contains an insert of 1222 bp, but no start codon was present. To
obtain the remaining 5'coding sequence a 5'-rapid amplification of cDNA
ends (5'-RACE) by PCR was performed. The PCR fragment was found to
contain the remaining 5'coding region preceded by 31 bp of untranslated
region (UTR). The total length of the assembled cDNA of Rana
esculenta test 1 was found to be 1462 bp. It contains an open
reading frame with the start codon at position 32 and the stop codon at
position 499. The 3'-UTR is 963 bp including 18 nucleotides of poly (A)
tail (Fig. 1
). The sequence following the
first methionine potentially encodes a protein of 155 amino acids
residues. The deduced amino acid sequence was compared with all
nonredundant GenBank entries and showed a low similarity to RLF and
relaxin from different species; for this reason, test 1 was named
"frog relaxin" (fRLX). The sequence shows a low identity at amino
acids level with RLF and relaxin known proteins (Table 1
). Although the low value of identity,
fRLX prepolypeptide contains the classical B-C-A domain configuration
present in all the insulin/relaxin family proteins. Restricting the
comparison among the B and A domains, forming the mature proteins, the
values are higher (Table 1
), showing that in all the members of the
family the cystein motifs present in the A and B domains were highly
conserved (Fig. 2
). The A-domain motif is
CC X3 C X8 C where
XN represents the number of residues comprising
no amino acids other than cystein. The B-domain motif is LCG
X10 C (Fig. 2
).

View larger version (55K):
[in this window]
[in a new window]
|
Figure 1. Nucleotide and amino acid sequence of the frog RLX
cDNA. The putative position of the signal peptidase cleavage site is
indicated as the possible delineation points for the A, B, and C
domains. The consensus receptor binding motif is boxed. The start and
stop codon are indicated in bold. The number on the
right represents nucleotide residues.
|
|
View this table:
[in this window]
[in a new window]
|
Table 1. Amino acid homology of frog RLX with mouse, human,
and pig RLF and human H1, H2, marsupial, and shark relaxin
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Figure 2. Multiple alignment of the deduced amino acid
sequences of the A and B domain of the fRLX with the mouse, human and
pig RLF and human H1, H2, marsupial and shark relaxin. Below the
alignment are the conserved B and A chain motifs; h, a hydrophobic
residue and C, cysteine. The lengths of the nonconserved sequences
linking the B and A chains are indicated in brackets.
|
|
From our phylogenetic analysis, RLF and relaxin sequences cluster in
two separate groups. The fRLX sequence is located at the basis of the
two groups, suggesting that it can represent an ancestral form of
relaxin and RLF (Fig. 3
).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 3. Relationship of fRLX to relaxin-like factors and
to relaxins isolated from other species. The sequences were aligned and
compared with construct a phylogenetic tree by using the UPGMA Kimura
method. The numbers indicate bootstrap values from 500 replicates.
Bootstrap values are expressed as percentage. Horizontal lines
indicates genetic distances. The Accession No. of the sequences
reported in the dendogram are: 3851207 (human RLF), 3850653 (marmoset
monkey RLF), 1708498 (pig RLF), 3719459 (bovine RLF), 9973367 (rat
RLF), 1754739 (mouse RLF), 1071943 (shark relaxin), 1710087 (rabbit
relaxin), 1710080 (chimpanzee relaxin 1), 132280 (human relaxin 1),
132309 (pig relaxin), and 2506784 (equine relaxin).
|
|
fRLX expression
The expression of fRLX gene in different frog tissues was analyzed
by a Northern blot using as a probe the test 1 cDNA insert. As shown in
Fig. 4A
, a single positive band is
present at high level exclusively in the testis. The size of this band,
estimated to be about 1.6 kb using as reference the 18S ribosomal RNA,
is very close to that of the total fRLX clone isolated. The amount of
RNA on each line was controlled using as a probe the frog ribosomal P1
cDNA (Accession No. AJ298875) (Fig. 4B
).

View larger version (88K):
[in this window]
[in a new window]
|
Figure 4. A, Northern blot analyses of total RNA extracted
from different Rana esculenta tissues hybridized with
fRLX probe. T, Testis; HG, harderian gland; L, liver; B, brain; K,
kidney; M, muscle. B, The illustrated membrane was rehybridized with a
fP1 probe as control for the equivalent loading of RNA.
|
|
RT-PCR analysis was performed to detect the fRLX expression also in the
ovary and in the oviduct. As shown in Fig. 5A
, a very low signal was evidenced both
in the ovary and oviduct (lanes 1 and 2, respectively) compared with
the strong signal observed in the testis (lane 3).

View larger version (80K):
[in this window]
[in a new window]
|
Figure 5. A, Northern blot analyses of total RNA extracted
from frog testes during the annual cycle hybridized with fRLX probe.
J/F, January/February; M/A, March/April; M/J, May/June; J/A,
July/August; S/O, September/October; N/D, November/December. B, The
illustrated membrane was rehybridized with a fP1 probe as control for
the equivalent loading of RNA.
|
|
From a semiquantitative analysis of mRNA levels, it results that the
levels of fRLX mRNA expression in ovary and oviduct are 0.3 and 0.7%,
respectively, compared with that of the testis.
Temporal expression of fRLX during spermatogenesis
To examine the expression of fRLX during spermatogenesis, a
Northern blot analysis was performed using total RNA from testes of
frogs collected twice a month during the annual cycle. fRLX mRNA was
detected at very high level during the months of January/February and
March/April, whereas it was detected at a low level in May/June and
July/August and at the lowest level in September/October (Fig. 6A
). The amount of RNA on each line was
controlled using as a probe the frog ribosomal P1 cDNA (Fig. 6B
).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 6. A, Agarose gel electrophoresis of RT-PCR products
of fRLX mRNA. M, Molecular weight marker VI (Roche
Diagnostic); C, control PCR; 1, ovary; 2, oviduct; 3, testis. B,
Agarose gel electrophoresis of RT-PCR products of HSP90 (Accession No.:
AJ309565) mRNA. M, molecular weight marker VIX (Roche
Diagnostic); 1, ovary; 2, oviduct; 3, testis.
|
|
Spatial localization of fRLX mRNA
To obtain an overall view of fRLX localization in situ
hybridization experiments were carried out on frog testis using
DIG-labeled sense and antisense RNA as a probe. The assays were carried
out on March testis, when the fRLX expression is at its highest level
and on September testis, when the fRLX expression is at its lowest
level. A strong signal was detected only in the interstitial tissue
around the germinal compartment in March (Fig. 7A
), whereas a weak interstitial signal
was present in the September testis (Fig. 7B
). No signal was detected
in March sense-treated testis (Fig. 7C
).

View larger version (56K):
[in this window]
[in a new window]
|
Figure 7. In situ hybridization of fRLX
antisense mRNA in the testes of March (A) and September (B); fRLF sense
probe (C). I, Interstitium; SPZ, spermatozoa. Magnification, A, B, and
C, 250x.
|
|
Cellular localization of fRLX mRNA
To ascertain the specific interstitial cellular type expressing
fRLX, we performed in situ hybridization on frog testis
treated with EDS, an alchilating agent which has a selective cytotoxic
effect on Leydig cells in some mammalian species and in the frog
Rana esculenta (25). Leydig cells are destroyed
after a single EDS injection and regenerate after 28 days. No fRLX mRNA
signal was detected on day 4 after the EDS injection (Fig. 8A
) when Leydig cells are affected,
whereas a strong fRLX mRNA signal reappeared in the interstitial
compartment on day 28 when a new population of Leydig cells appear in
the interstitial compartment after 28 days (Fig. 8B
).

View larger version (76K):
[in this window]
[in a new window]
|
Figure 8. In situ hybridization of fRLX
antisense mRNA in the frog testes on day 4 (A) and on day 28 (B) after
a single injection of EDS. Magnification, A and B, 170x.
|
|
Pituitary control on the fRLX expression
To determine the pituitary action on fRLX expression in
situ hybridization was performed on testes of hypophysectomized
(PDX) frogs kept in captivity for 30 days. As control, we used testes
of intact animals. The hybridization signal was present in the
interstitial compartment of both groups, but it was stronger in the
interstitium of the intact animals (Fig. 9
, A and B). The testis of PDX animals
shows the typical characteristic of hypophysectomy: the interstitial
compartment becomes hypertrophic, whereas the germinal compartment
showed signs of degeneration, such as seminiferous tubules without
spermatids (SPT), and very few secondary spermatogonia (II SPG),
whereas secondary spermatocytes (II SPC) were rare. Many degenerating
nests containing primary spermatocytes (I SPC) were observed.

View larger version (79K):
[in this window]
[in a new window]
|
Figure 9. In situ hybridization of fRLX
antisense mRNA in the hypophysectomized frog testes (A) and in the
control frog testes (B). After the hybridization the sections were
stained with hematoxylin/eosin. I, interstitium; II SPG, secondary
spermatogonia; I SPC, primary spermatocytes; II SPC, secondary
spermatocytes; SPT, spermatids; SPZ, spermatozoa;
arrows, primary spermatogonia; stars,
degenerating nets. Magnification: A, x320; B, x250.
|
|
 |
Discussion
|
|---|
In the present paper, we report the isolation of a frog
relaxin/insulin family member (fRLX) cDNA and the characterization of
the spatial expression of the corresponding transcript. The homology
between fRLX and other proteins in this family is based on the primary
amino acid sequence, considering their characteristic functional domain
arrangements, and on the six conserved cysteins residues, necessary to
create the inter and intrachain disulphide linkage, characteristic of
other relaxin-insulin family members (26). The
prepropolypeptide structure, shared by most members of the family,
consists of the signal peptide and B, C, and A domains located at N-
and C-terminus respectively; a post transcriptional modification
produces the removal of the signal peptide and of the C domain
(27). The fRLX prepropolypeptide has a modest homology to
the mammalian RLFs and relaxins; furthermore, restricted sequence
comparison between B and A domains revealed a higher homology [40%
and 30.8% to B and A domains of mouse RLF (3), 50% and
41.7% to B and A domains of marsupial relaxin (28)]. The
C domain sequence diverged greatly among family proteins and showed no
similarity to any known proteins. This diversity could be due to a lack
of selection pressure in this region.
fRLX protein, similar to the mammalian RLF and the other relaxin known
proteins, contains a conserved amino acid motif, R-XXX-R, close to the
first cystein of the B domain. Because this motif has been shown to be
important for relaxin binding to its putative receptor in many tissues
(29, 30, 31), it has been hypothesized that the relaxin
receptor could be recognized by RLF with lower affinity
(32). Alteration of basic residues in this binding motif
completely abolished receptor interaction (29, 33, 34).
The phylogenetic tree for amino acid sequences related to RLF and
relaxin proteins suggests that fRLX may be grouped with shark and
mammalian relaxins. It is to be noted that fRLX, as the mammalian RLFs,
is highly expressed in the testicular Leydig cells and lowly expressed
in the ovary and in the female tract, whereas mammalian relaxins are
classical endocrine hormones, produced by the ovary, and targeting the
reproductive system to ripen the cervix, elongate the pubic symphysis
and inhibit uterine contraction (35, 36).
Taken together, our results with phylogenetic analysis evidenced that
fRLX sequence can represent an ancestral form of relaxin from which
both modern mammalian relaxin and RLF might have evolved, respectively,
for female and male functions.
The frog testis fRLX mRNA is a specific transcript found in the
interstitial compartment and absent in the tubular compartment.
Analyses of the Northern blot revealed a different expression of the
transcript throughout the year. fRLX mRNA is more abundant in January
and February. It reaches a peak in March-April then gradually declines
from May onwards with a minimum in September-October. It is of interest
to remember that circulating levels of androgens in Rana
esculenta are relatively high when fRLX mRNA is more abundant
(37). At the same time, androgens are necessary for
spermatogonial proliferation and spermatid formation. Therefore, fRLX
expression pattern correlates well with the frog steroidogenic and
spermatogenetic wave.
It has been hypothesized that mouse RLF is a testicular factor that
plays an essential role in testis descent, which is involved in
gubernacolum development (15, 16) thus making the testis
avail a slightly lower (compared with body) temperature threshold
necessary for active spermatogenesis. These studies also mentioned that
RLF knockout mice show abnormal spermatogenesis. However, normal
spermatogenesis was observed in the surgically descended testis of
RLF-deficient mice, strongly suggesting that in mice, RLF is not
essential for germ cell development (15). In lower
vertebrates, like the frog, where testicular descent does not occur,
spermatogenesis is susceptible to seasonal thermal influence
(17). The fact that the seasonal pattern of fRLX
expression is consistent with seasonal testicular cycle strongly
suggests a role of this factor in testicular activity.
In an attempt to obtain more information about the hypophysial
influences on fRLX expression, if any, we investigated the presence of
fRLX transcript in the testes of PDX animals after 30 days from
surgical depletion. The fRLX expression was detected at a lower level
in the interstitial compartment of the PDX frogs compared with that of
the intact animals. This preliminary result seems to indicate that the
fRLX expression could be under hypophysal control. A pituitary control
of RLF expression has been indicated using hypogonadic mice lacking an
active pituitary-gonadal axis caused by a deletion in the
hypothalamically expressed gene for GnRH with consequent gonadotropin
deficiency (38, 39, 40) in which RLF expression is totally
absent, suggesting that Leydig cells seems to be arrested in a
prepubertal state of differentiation (41).
In conclusion, our present study is the first report on the isolation
and characterization of a new member of the relaxin/insulin family in a
nonmammalian vertebrate, the frog Rana esculenta. EDS
administration showed that Leydig cells are the specific interstitial
cell type expressing fRLX. Its expression changes during the
spermatogenetic cycle, suggesting that it might contribute to the
efficiency of spermatogenesis in these species with seasonal breeding
and it seems to be modulated by pituitary. In addiction, fRLX is
expressed at a very low level also in the ovary and oviduct. fRLX may
be considered a new marker for the study of the testicular activity in
the frog Rana esculenta.
 |
Acknowledgments
|
|---|
We thank Dr. I. D. Morris (Edinburgh, UK) for EDS gift and
Dr. G. Procaccini of the Stazione Zoologica "A. Dohrn" for his kind
help in the construction of the phylogenetic tree.
 |
Footnotes
|
|---|
1 This work was supported by MURST (ex 40% "Geremia") and Target
Project on Biotechnology within the CNR grants. The EMBL/DDBJ/GeneBank
accession no. for frog RLX is AJ298874. 
2 All the authors contributed equally in the preparation of the
manuscript. 
Received December 27, 2000.
 |
References
|
|---|
-
Adham IM, Burkhardt E, Benahmed M, Engel W 1993 Cloning of a cDNA for a novel insuline-like peptide of the
testicular Leydig cells. J Biol Chem 268:2666826672[Abstract/Free Full Text]
-
Burkhardt E, Adham IM, Hobohm U, Murphy D, Sander C,
Engel W 1994 A human cDNA coding for a Leydig insulin-like peptide
(Ley-I-L). Hum Genet 94:9194[CrossRef][Medline]
-
Pusch W, Balvers M, Ivell R 1996 Molecular cloning
and expression of the relaxin-like factor from the mouse testis.
Endocrinology 137:30093013[Abstract]
-
Gyesik M, Sherwood OD 1998 Localization of
specific relaxin-binding cells in the ovary and testis of pigs. Biol
Reprod 59:401409[Abstract/Free Full Text]
-
Burkhardt E, Adham IM, Brosig B, Gastmann A, Mattei MG,
Engel W 1994 Structural organization of the porcine and human
genes coding for a Leydig cell-specific insulin-like peptide (Ley-I-L)
and chromosomal localization of the human gene (INSL 3). Genomics 20:1319[CrossRef][Medline]
-
Hombach-Klonisch S, Tetens F, Kauffold J, Steger K,
Fischer B, Klonisch T 1999 Molecular cloning and localization of
caprine relaxin-like factor (RLF) mRNA within the goat testis. Mol
Reprod Dev 53:135141[CrossRef][Medline]
-
Zarreh-Hoshyari-Khah MR, Einspanier A, Ivell R 1999 Differential splicing and expression of the relaxin-like factor
gene in reproductive tissues of the marmoset monkey (Callithrix
jacchus). Biol Reprod 60:445453[Abstract/Free Full Text]
-
Zimmermann S, Schöttler P, Engel W, Adham IM 1997 Mouse Leydig insulin-like (Ley-I-L) gene: structure and expression
during testis and ovary development. Mol Reprod Dev 47:3038[CrossRef][Medline]
-
Ivell R 1997 Biology of the relaxin-like factor
(RLF). Rev Reprod 2:133138[Abstract]
-
Tashima LS, Hieber AD, Greenwood FC, Bryant-Greenwood
GD 1995 The human Leydig insulin-like (Ley-I-L) gene is expressed
in the corpus luteum and trophoblast. J Clin Endocrinol Metab 80:707710[Abstract]
-
Bathgate RAD, Balvers M, Hunt N, Ivell R 1996 Relaxin-like factor gene is highly expressed in the bovine ovary of the
cycle and pregnancy: sequence and messenger ribonucleic acid analysis.
Biol Reprod 55:14521457[Abstract]
-
Roche PJ, Crawford RJ, Tregear GW 1993 A single
copy relaxin-like gene sequence is present in sheep. Mol Cell
Endocrinol 91:2128[CrossRef][Medline]
-
Zimmermann S, Schwärzler A, Buth S, Engel W, Adham
IM 1999 Transcription of the Leydig insulin-like gene is mediated
by steroidogenic factor-1. Mol Endocrinol 12:706713[Abstract/Free Full Text]
-
Adham IM, Zimmermann S, Engel W 1997 Leydig
insulin-like hormone-deficient mice show premeiotic arrest and germ
cell death. Reprod Domest Anim 32:73
-
Zimmermann S, Steding G, Emmen JMA, Brinkmann AO,
Nayernia K, Holstein AF, Engel W, Adham IM 1999 Targeted
distruption of the Insl3 gene causes bilateral
cryptorchidism. Mol Endocrinol 13:681691[Abstract/Free Full Text]
-
Nef S, Parada LF 1999 Cryptorchidism in mice mutant
for Insl3. Nat Genet 22:295299[CrossRef][Medline]
-
Rastogi RK, Iela L 1992 Spermatogenesis in
amphibia: dynamics and regulation. In: Dellai R (ed) Sex Origin and
Evolution. Mucchi, Modena, pp 231249
-
Sprenger H, Konrad L, Rischowsky E, Gemsa D 1995 RNA extraction from gastrointestinal tract and pancreas by a modified
Chomczynski and Sacchi method. Biotechniques 19:340343[Medline]
-
Sambroock J, Fritsch EF, Maniatis T 1989 Molecular
Cloning. A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory
Press, New York
-
Aniello F, Branno M, Marra P, Chieffi-Baccari G, Di
Matteo L, Minucci S 1996 Molecular cloning of a novel mRNA
(Harderin) specifically and highly expressed in the Harderian gland of
the frog Rana esculenta. Biochem Mol Biol Int 38:401408[Medline]
-
Sanger F, Nicklen S, Coulson AR 1975 A rapid method
for determine sequences in DNA by primed synthesis with DNA polymerase.
J Mol Biol 94:441445[CrossRef][Medline]
-
Hall TA 1999 BioEdit: a user-friendly biological
sequence alignment editor and analysis program for windows 95/98/NT.
Nucleic Acids Symp Ser 41:9598
-
Felsenstein J 1989 PHYLIP: Phylogeny Interference
Package, Ver 3.4. Cladistics 5:164166
-
Rastogi RK, Chieffi G 1972 Hypotalamic control of
the hypophyseal gonadotropic function in the adult male green frog,
Rana esculenta. J Exp Zool 181:263270[Medline]
-
Minucci S, Fasano S, Pierantoni R 1992 The use of
EDS in investigation of the testicular activity in vertebrates. In:
Alexander JC (ed) Advances in Comparative Endocrinology. Compilers
International, Bangalore-Varanesi-Texas, 1:117125
-
Blindell TL, Humbel RE 1980 Hormone families:
pancreatic hormones and homologous growth factors. Nature 187:781787
-
Steiner DF 1998 The protein convertases. Curr Opin
Chem Biol 2:3139[CrossRef][Medline]
-
Parry LJ, Rust W, Ivell R 1997 Marsupial relaxin:
complementary deoxyribonucleic acid sequence and gene expression in the
female and male tammar wallaby, Macropus eugeii. Biol Reprod 57:119127[Abstract]
-
Bullesbach EE, Yang S, Schwabe C 1992 The
receptor-binding site of human relaxin II. J Biol Chem 267:2295722960[Abstract/Free Full Text]
-
Eigenbrot C, Randal M, Quan C, Burnier J, OConnell L,
Rinderknecht E, Kossiakoff AA 1991 X-ray structure of human
relaxin at 1.5 A. Comparison to insulin and implications for receptor
binding determinants. J Mol Biol 221:1521[Medline]
-
Bullesbach EE, Schwabe C 1988 On the receptor
binding site of relaxins. Int J Pept Protein Res 32:361367[Medline]
-
Sherwood OD, Downing SJ, Guico-Lamm ML, Hwang JJ,
ODay-Bowman MB, Fields PA 1993 The physiological effects of
relaxin during pregnancy: studies in rats and pigs. Oxf Rev Reprod Biol 15:143189[Medline]
-
Bullesbach EE, Schwabe C 1995 A novel Leydig cells
cDNA-derived protein is a relaxin-like factor. J Biol Chem 270:1601116015[Abstract/Free Full Text]
-
Schwabe C, Bullesbach EE 1985 Relaxin: structures,
functions, promises and non-evolution. FASEB J 8:11521160[Abstract]
-
Bryant-Greenwood GD, Schwabe C 1994 Human relaxin:
chemistry and biology. Endocr Rev 15:526[CrossRef][Medline]
-
Sherwood OD 1994 Relaxin. In: Knobil E, Neill JD
(eds) Physiology of Reproduction. Academic Press, New York, pp
8611009
-
Varriale B, Pierantoni R, Di Matteo L, Minucci S, Fasano
S, DAntonio M, Chieffi G 1986 Plasma and testicular estradiol
and plasma androgen profile in the male frog. Rana esculenta, during
the annual cycle. Gen Comp Endocrinol 64:401404[CrossRef][Medline]
-
Scott IS, Charlton HM, Cox BS, Grocock CA, Sheffield JW,
OShaughnessy PJ 1990 Effect of LH injections on testicular
steroidogenesis, cholesterol side-chain cleavage P450 mRNA content and
Leydig cell morphology in hypogonadal mice. J Endocrinol 125:131138[Abstract/Free Full Text]
-
Cattenach BM, Iddon CA, Charlton HM, Chiappa SA, Fink
G 1997 Gonadotropin releasing hormone deficiency in a mutant mouse
with hypogonadism. Nature 269:338340
-
Charlton HM, Halpin DMG, Iddon C, Rosie R, Levy G,
McDowell IFW, Megson A, Morris JF, Bramwell A, Speight A, Ward BJ,
Broadhead J, Davey-Smith G, Fink G 1983 The effect on daily
administration of single and multiple injection of gonadotropin
releasing hormone on pituitary and gonadal function in the hypogonadal
(hpg) mouse. Endocrinology 113:535544[Medline]
-
Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E,
Mukhopadhyay AK, Hanks E, Charlton M, Ivell R 1998 Relaxin-like
factor expression as a marker of differentiation in the mouse testis
and ovary. Endocrinology 139:29602970[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
G. De Rienzo, F. Aniello, M. Branno, G. Izzo, and S. Minucci
The expression level of frog relaxin mRNA (fRLX), in the testis of Rana esculenta, is influenced by testosterone
J. Exp. Biol.,
October 1, 2006;
209(19):
3806 - 3811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ivell and R. A.D. Bathgate
Reproductive Biology of the Relaxin-Like Factor (RLF/INSL3)
Biol Reprod,
September 1, 2002;
67(3):
699 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. D. Bathgate, C. S. Samuel, T. C. D. Burazin, S. Layfield, A. A. Claasz, I. G. T. Reytomas, N. F. Dawson, C. Zhao, C. Bond, R. J. Summers, et al.
Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene. NOVEL MEMBERS OF THE RELAXIN PEPTIDE FAMILY
J. Biol. Chem.,
January 4, 2002;
277(2):
1148 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|